These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33836034)

  • 1. SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future.
    Rasmussen S; Petersen MS; Høiby N
    PLoS One; 2021; 16(4):e0249733. PubMed ID: 33836034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections.
    Russell TW; Golding N; Hellewell J; Abbott S; Wright L; Pearson CAB; van Zandvoort K; Jarvis CI; Gibbs H; Liu Y; Eggo RM; Edmunds WJ; Kucharski AJ;
    BMC Med; 2020 Oct; 18(1):332. PubMed ID: 33087179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
    Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
    Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Espenhain L; Tribler S; Sværke Jørgensen C; Holm Hansen C; Wolff Sönksen U; Ethelberg S
    Eur J Epidemiol; 2021 Jul; 36(7):715-725. PubMed ID: 34420152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.
    Rivett L; Sridhar S; Sparkes D; Routledge M; Jones NK; Forrest S; Young J; Pereira-Dias J; Hamilton WL; Ferris M; Torok ME; Meredith L; ; Curran MD; Fuller S; Chaudhry A; Shaw A; Samworth RJ; Bradley JR; Dougan G; Smith KG; Lehner PJ; Matheson NJ; Wright G; Goodfellow IG; Baker S; Weekes MP
    Elife; 2020 May; 9():. PubMed ID: 32392129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study.
    van Zandvoort K; Jarvis CI; Pearson CAB; Davies NG; ; Ratnayake R; Russell TW; Kucharski AJ; Jit M; Flasche S; Eggo RM; Checchi F
    BMC Med; 2020 Oct; 18(1):324. PubMed ID: 33050951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study.
    Martinelli D; Fortunato F; Mazzilli S; Bisceglia L; Lopalco PL; Prato R
    Biomed Res Int; 2022; 2022():3401566. PubMed ID: 35005026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach.
    Russo L; Anastassopoulou C; Tsakris A; Bifulco GN; Campana EF; Toraldo G; Siettos C
    PLoS One; 2020; 15(10):e0240649. PubMed ID: 33125393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of travelling on the COVID-19 infection cases in Germany.
    Schäfer M; Wijaya KP; Rockenfeller R; Götz T
    BMC Infect Dis; 2022 May; 22(1):455. PubMed ID: 35549671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience.
    Ansah JP; Matchar DB; Shao Wei SL; Low JG; Pourghaderi AR; Siddiqui FJ; Min TLS; Wei-Yan AC; Ong MEH
    PLoS One; 2021; 16(3):e0248742. PubMed ID: 33784332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 pandemic: key considerations for the epidemic and its control.
    Ørskov S; Nielsen BF; Føns S; Sneppen K; Simonsen L
    APMIS; 2021 Jul; 129(7):408-420. PubMed ID: 33932317
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.